Pear Therapeutics, Inc.: Pear Therapeutics Presents Real-Wor

Somryst is the only FDA-authorized prescription digital therapeutic (PDT) for the treatment of chronic insomnia Analysis demonstrated potential per-patient cost reductions over 24 months of

Related Keywords

Vienna , Wien , Austria , United States , American , Meara Murphy , Yuri Maricich , Pabout Somryst , Health Care Provider , Emergency Department , Software Precertification Pilot Program , Nasdaq , American College Of Physicians , American Academy Of Sleep Medicine , Pear Therapeutics Us Inc , Corporate Communications , Pear Therapeutics Inc , Chief Medical Officer , American Academy , Sleep Medicine , American College , Important Safety , Cognitive Behavioral Therapy , Health Care , Clinician Brief Summary Instructions , Pear Therapeutics , Precertification Pilot , Healthcare Resource Utilization , Chronic Insomnia , After Treatment , Pear , Herapeutics , Presents , Meal , World , Data , Showing , Reduction , Healthcare , Resource , Utilization , Ssociated , Costs , Adults , Sing , Omryst , Spor , Europe ,